LA
ORTX

Legacy Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Legacy Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-295
Closed -$41K – 347
2019
Q2 		$41K Hold
295
– – 0.03% 218
2019
Q1 		$53K Buy
+295
New +$44.3K 0.02% 209

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Legacy Advisors's ORTX Position: Q3 2019 in Review

Legacy Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2019, closing a stake of 295 shares — an estimated $41K sold.

Legacy Advisors first reported a position in ORTX in Q1 2019 and held it in 2 quarters. The position peaked at $53K in Q1 2019. 62 funds tracked by Wall St. Rank hold ORTX as of Q3 2019.

  • Legacy Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Legacy Advisors sold 295 Orchard Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $41K.
  • Legacy Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 2 quarters.
  • Legacy Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $53K in Q1 2019.
  • 62 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2019.

Based on Legacy Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.